$PRTA
PROTHENA CORP PUBLIC LTD CO Stock $prta

$prta Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000155905315000042 Filed on November 02, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$307.0K	$429.0K	$1.486M
YoY Change	-84.75%	-71.13%	769.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.630M	$5.910M	$4.230M
YoY Change	32.34%	39.72%	24.78%
% of Gross Profit
Research & Development	$17.89M	$17.19M	$10.39M
YoY Change	76.95%	65.43%	63.64%
% of Gross Profit
Depreciation & Amortization	$220.0K	$200.0K	$200.0K
YoY Change	15.79%	0.0%	100.0%
% of Gross Profit
Operating Expenses	$24.52M	$23.09M	$14.62M
YoY Change	62.18%	57.96%	50.13%
Operating Profit		-$22.66M	-$13.13M
YoY Change		72.56%	37.28%
Interest Expense	$80.00K	$50.00K	$20.00K
YoY Change	166.67%	150.0%	100.0%
% of Operating Profit
Other Income/Expense, Net	-$20.00K	-$77.00K	$191.0K
YoY Change	-122.22%	-140.31%	1264.29%
Pretax Income	-$24.16M	-$22.74M	-$12.94M
YoY Change	85.99%	75.71%	35.48%
Income Tax	$0.00	$238.0K	$241.0K
% Of Pretax Income
Net Earnings	-$24.16M	-$22.98M	-$13.18M
YoY Change	84.26%	74.3%	36.05%
Net Earnings / Revenue	-7868.73%	-5355.71%	-887.08%
Basic Earnings Per Share	-$0.76	-$0.73	-$0.48
Diluted Earnings Per Share	-$0.76	-$0.73	-$0.48
COMMON SHARES
Basic Shares Outstanding	31.52M shares	31.44M shares	27.37M shares
Diluted Shares Outstanding		31.44M shares	27.37M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$370.6M	$387.8M	$306.2M
YoY Change	26.23%	26.65%	200.49%
Cash & Equivalents	$370.6M	$387.8M	$306.2M
Short-Term Investments
Other Short-Term Assets	$6.300M	$5.000M	$1.600M
YoY Change	65.79%	212.5%	45.45%
Inventory
Prepaid Expenses
Receivables	$509.0K	$814.0K	$967.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$377.4M	$393.6M	$308.8M
YoY Change	26.18%	27.45%	200.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.862M	$2.930M	$3.282M
YoY Change	23.74%	-10.73%	-8.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.121M	$7.000K	$1.500M
YoY Change		-99.53%	102.98%
Total Long-Term Assets	$7.833M	$5.354M	$4.778M
YoY Change	56.41%	12.06%	-4.4%
TOTAL ASSETS
Total Short-Term Assets	$377.4M	$393.6M	$308.8M
Total Long-Term Assets	$7.833M	$5.354M	$4.778M
Total Assets	$385.2M	$398.9M	$313.6M
YoY Change	26.67%	27.21%	190.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.519M	$4.058M	$1.240M
YoY Change	-4.3%	227.26%	38.39%
Accrued Expenses	$16.60M	$13.00M	$7.000M
YoY Change	207.41%	85.71%	45.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$22.22M	$18.56M	$9.971M
YoY Change	84.53%	86.12%	29.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$126.0K	$126.0K	$2.100M
YoY Change		-94.0%	50.0%
Total Long-Term Liabilities	$2.351M	$2.419M	$2.065M
YoY Change	7.45%	17.14%	47.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.22M	$18.56M	$9.971M
Total Long-Term Liabilities	$2.351M	$2.419M	$2.065M
Total Liabilities	$24.57M	$20.98M	$12.04M
YoY Change	72.68%	74.29%	31.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$129.1M	-$104.9M	-$35.38M
YoY Change	166.24%	196.62%	16.82%
Common Stock	$317.0K	$315.0K	$274.0K
YoY Change	15.69%	14.96%	54.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$360.7M	$378.0M	$301.6M
YoY Change
Total Liabilities & Shareholders Equity	$385.2M	$398.9M	$313.6M
YoY Change	26.67%	27.21%	190.54%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$24.16M	-$22.98M	-$13.18M
YoY Change	84.26%	74.3%	36.05%
Depreciation, Depletion And Amortization	$220.0K	$200.0K	$200.0K
YoY Change	15.79%	0.0%	100.0%
Cash From Operating Activities	-$19.69M	-$16.91M	-$12.27M
YoY Change	57.27%	37.82%	19.13%
INVESTING ACTIVITIES
Capital Expenditures	-$980.0K	-$330.0K	-$110.0K
YoY Change	1300.0%	200.0%	-52.17%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$980.0K	-$330.0K	-$110.0K
YoY Change	2350.0%	200.0%	-52.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.450M	2.650M	14.68M
YoY Change	-17350.0%	-81.95%	-12333.33%
NET CHANGE
Cash From Operating Activities	-19.69M	-16.91M	-12.27M
Cash From Investing Activities	-980.0K	-330.0K	-110.0K
Cash From Financing Activities	3.450M	2.650M	14.68M
Net Change In Cash	-17.22M	-14.59M	2.300M
YoY Change	36.88%	-734.35%	-121.6%
FREE CASH FLOW
Cash From Operating Activities	-$19.69M	-$16.91M	-$12.27M
Capital Expenditures	-$980.0K	-$330.0K	-$110.0K
Free Cash Flow	-$18.71M	-$16.58M	-$12.16M
YoY Change	50.28%	36.35%	20.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-304000	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001559053
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31522750	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Prothena Corp plc
	dei	Trading Symbol TradingSymbol	PRTA
	prta	Accrued Offering Costs AccruedOfferingCosts	45000	USD
	prta	Accrued Offering Costs AccruedOfferingCosts	12000	USD
CY2014Q4	prta	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	2285000	USD
CY2015Q3	prta	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	9522000	USD
CY2014Q3	prta	Collaboration Revenue CollaborationRevenue	1349000	USD
	prta	Collaboration Revenue CollaborationRevenue	48429000	USD
CY2015Q3	prta	Collaboration Revenue CollaborationRevenue	429000	USD
	prta	Collaboration Revenue CollaborationRevenue	1300000	USD
CY2014Q4	prta	Deferred Shares Par Value DeferredSharesParValue	22
CY2015Q3	prta	Deferred Shares Par Value DeferredSharesParValue	22
CY2014Q4	prta	Deferred Shares Share Issued DeferredSharesShareIssued	0	shares
CY2015Q3	prta	Deferred Shares Share Issued DeferredSharesShareIssued	0	shares
CY2014Q4	prta	Deferred Shares Share Outstanding DeferredSharesShareOutstanding	0	shares
CY2015Q3	prta	Deferred Shares Share Outstanding DeferredSharesShareOutstanding	0	shares
CY2014Q4	prta	Deferred Shares Shares Authorized DeferredSharesSharesAuthorized	10000	shares
CY2015Q3	prta	Deferred Shares Shares Authorized DeferredSharesSharesAuthorized	10000	shares
CY2014Q4	prta	Deferred Shares Value DeferredSharesValue	0	USD
CY2015Q3	prta	Deferred Shares Value DeferredSharesValue	0	USD
	prta	Gain Losson Sublease GainLossonSublease	-400000	USD
	prta	Gain Losson Sublease Noncash Portion GainLossonSubleaseNoncashPortion	0	USD
	prta	Gain Losson Sublease Noncash Portion GainLossonSubleaseNoncashPortion	-261000	USD
CY2015Q3	prta	Lessee Leasing Arrangements Operating Leases Optionto Terminate Date LesseeLeasingArrangementsOperatingLeasesOptiontoTerminateDate	2020-08-31
	prta	Numberof Votes NumberofVotes	1	vote
CY2015Q3	prta	Purchaseand Contractual Obligation Due After Fifth Year PurchaseandContractualObligationDueAfterFifthYear	905000	USD
CY2015Q3	prta	Purchaseand Contractual Obligation Due For Remainderof Year PurchaseandContractualObligationDueForRemainderofYear	3212000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-688000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-704000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	412000	USD
CY2015Q3	prta	Purchaseand Contractual Obligation Duein Fifth Year PurchaseandContractualObligationDueinFifthYear	123000	USD
CY2015Q3	prta	Purchaseand Contractual Obligation Duein Fourth Year PurchaseandContractualObligationDueinFourthYear	132000	USD
CY2015Q3	prta	Purchaseand Contractual Obligation Duein Second Year PurchaseandContractualObligationDueinSecondYear	132000	USD
CY2015Q3	prta	Purchaseand Contractual Obligation Duein Third Year PurchaseandContractualObligationDueinThirdYear	132000	USD
CY2015Q3	prta	Purchaseand Contractual Obligation Total PurchaseandContractualObligationTotal	4636000	USD
CY2015Q1	prta	Sublease Leases Optional Extension Term SubleaseLeasesOptionalExtensionTerm	P1Y
CY2015Q1	prta	Sublease Leases Term SubleaseLeasesTerm	P3Y
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4722000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4058000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1729000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	814000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	57000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2014Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	98000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	98000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1169000	USD
CY2015Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	442000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4711000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5136000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	338106000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	482584000	USD
CY2014Q4	us-gaap	Assets Assets	304116000	USD
CY2015Q3	us-gaap	Assets Assets	398930000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	299275000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	393576000	USD
CY2014Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	4841000	USD
CY2015Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	5354000	USD
CY2014Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	137000	USD
CY2015Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	159000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	176677000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	306153000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293579000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	387802000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	129476000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	94223000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27388005	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31521550	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27388005	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31521550	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	274000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	315000	USD
CY2015Q3	us-gaap	Contractual Obligation ContractualObligation	1602000	USD
CY2015Q3	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	905000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	123000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	123000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	123000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	123000	USD
CY2015Q3	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	205000	USD
CY2014Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	172000	USD
CY2015Q3	us-gaap	Deferred Rent Credit DeferredRentCredit	268000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2090000	USD
CY2015Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2195000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	167000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	174000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1720000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2417000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Depreciation Depreciation	500000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Depreciation Depreciation	600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	549000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	588000	USD
CY2014Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	30000	USD
CY2015Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.89
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.89
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3138000	USD
CY2015Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3500000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	262000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	2351000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	262000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	2351000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4230000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14040000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5905000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16476000	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	34000	USD
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-30000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12941000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6648000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	112000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-22738000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-55756000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	241000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	688000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	238000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	699000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	988000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	442000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3195000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7502000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	967000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-915000	USD
CY2014Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	19000	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	54000	USD
CY2015Q3	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	50000	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	116000	USD
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2214000	USD
CY2015Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2254000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	14227000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	20977000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	304116000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	398930000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12039000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	18558000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2188000	USD
CY2015Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2419000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5481000	USD
CY2015Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5653000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	118095000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	137394000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-459000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-397000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11840000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-42774000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-13182000	USD
	us-gaap	Net Income Loss NetIncomeLoss	5960000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-22976000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-56455000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	191000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	192000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-77000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	14618000	USD
	us-gaap	Operating Expenses OperatingExpenses	42385000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	23090000	USD
	us-gaap	Operating Expenses OperatingExpenses	57025000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13132000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	6456000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-22661000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-55725000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4975000	USD
CY2015Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4978000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	126000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	172000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	138000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-127000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-147000	USD
CY2014Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	496000	USD
CY2015Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	768000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	459000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	397000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3770000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4786000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	117391000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	131481000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	442000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3562000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7832000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8066000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3121000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2930000	USD
CY2015Q3	us-gaap	Purchase Obligation PurchaseObligation	3034000	USD
CY2015Q3	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2015Q3	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	USD
CY2015Q3	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	9000	USD
CY2015Q3	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	9000	USD
CY2015Q3	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	9000	USD
CY2015Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	3007000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10388000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28345000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17185000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40549000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48491000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-104946000	USD
CY2014Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	137000	USD
CY2015Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0	USD
CY2014Q3	us-gaap	Revenues Revenues	1486000	USD
	us-gaap	Revenues Revenues	48841000	USD
CY2015Q3	us-gaap	Revenues Revenues	429000	USD
	us-gaap	Revenues Revenues	1300000	USD
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1418000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4199000	USD
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3017000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7136000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	289889000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	377953000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	964000	shares
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27370000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24722000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31441000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29893000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27370000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23758000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31441000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29893000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates, including critical accounting policies or estimates related to revenue recognition, share-based compensation and research and development expenses. The Company bases its estimates on historical experience and on various other market specific and other relevant assumptions that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Because of the uncertainties inherent in such estimates, actual results may differ materially from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001559053-15-000042-index-headers.html	Edgar Link	pending
0001559053-15-000042-index.html	Edgar Link	pending
0001559053-15-000042.txt	Edgar Link	pending
0001559053-15-000042-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
prta-20150930.xml	Edgar Link	completed
prta-20150930.xsd	Edgar Link	pending
prta-20150930_cal.xml	Edgar Link	unprocessable
prta-20150930_def.xml	Edgar Link	unprocessable
prta-20150930_lab.xml	Edgar Link	unprocessable
prta-20150930_pre.xml	Edgar Link	unprocessable
prta2015q310-q.htm	Edgar Link	pending
prta2015q310-qxex311.htm	Edgar Link	pending
prta2015q310-qxex312.htm	Edgar Link	pending
prta2015q310-qxex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRTA
PROTHENA CORP PUBLIC LTD CO Stock $prta

2015 Q4 Form 10-Q Financial Statement

#000155905315000042 Filed on November 02, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRTA PROTHENA CORP PUBLIC LTD CO Stock $prta

2015 Q4 Form 10-Q Financial Statement

#000155905315000042 Filed on November 02, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRTA
PROTHENA CORP PUBLIC LTD CO Stock $prta